SOPHiA GENETICS SA·4

May 20, 4:02 PM ET

Valente Manuela 4

Research Summary

AI-generated summary

Updated

SOPHiA GENETICS (SOPH) CPO Manuela Valente Sells 380 Shares

What Happened
Manuela Valente, Chief People Officer of SOPHiA GENETICS SA (SOPH), sold 380 shares on 2026-05-19 in open-market transactions. The filing reports a weighted-average price of $4.60 per share (total proceeds ~$1,747); individual trades ranged $4.54–$4.65. According to the filing, the sales were to satisfy tax withholding obligations tied to the vesting of restricted stock units and were executed under a pre-established Rule 10b5-1(c) plan (non-discretionary).

Key Details

  • Transaction date: 2026-05-19; Form 4 filed 2026-05-20 (timely filing).
  • Reported sale: 380 shares; weighted-average price $4.60; price range $4.54–$4.65.
  • Proceeds: approximately $1,747.
  • Purpose/footnote F1: Shares sold to cover tax withholding from RSU vesting on 2026-05-18; sales effected under a pre-established 10b5-1(c) plan (non-discretionary).
  • Pricing detail/footnote F2: Price is a weighted average; Reporting Person can provide per-trade breakdown on request.
  • Shares owned after transaction: not stated in the provided filing.

Context
These sales were tax-withholding related and executed under a Rule 10b5-1 plan, which is commonly used for routine, pre-planned dispositions and is not an ad hoc insider sell signal. The transaction size ($~1.7K) is small relative to typical market moves and does not, by itself, indicate management sentiment about the company’s outlook.